Near the end of November 2019 Aurora Cannabis (ACB) found it would no longer be able to sell medical cannabis to the German …
Despite the promising launch of Cannabis 2.0 products next week, a stock like HEXO (HEXO) still trades at yearly lows down 75% from …
It’s safe to say things aren’t so rosy for New Age Beverages (NBEV) stock. Shares have plummeted around 65% year-to-date in line with …
Public opinion on cannabis is changing quickly, growing ever more lenient. In a short span, less than a lifetime, we’ve seen a series …
The Canadian cannabis market is heading into a major catalyst with the unleashing of Cannabis 2.0 products in mid-December.
The major benefit to U.S.
A big thesis of the Canadian cannabis LPs investment story was global expansion. The news last week of Aurora Cannabis (ACB) being blocked …
The FDA recently sent 15 warning letters to privately held companies concerning violations surrounding the inclusion of CBD in human and animal drugs, …
While the cannabis sector faces capital concerns, Aphria (APHA) was just able to secure a reasonably priced financing. The move possibly changes the …
There has been a lot of hype concerning what has been dubbed Cannabis 2.0 in Canada, as the country legalized a variety of …
